406.2 ð åèçïŒé«åž«åè / PGY OSCEïŒ
406.2.0.1 ð Cram Sheet
406.2.0.1.1 ð¥ é« yield 12
- Cycle: 28d (24-38), bleed 4-8d, < 80 mL
- PALM-COEIN AUB: PALM structural, COEIN non-structural
- Amenorrhea workup 1st: pregnancy test
- Primary amenorrhea: no menarche 15 (with sec) / 13 (without)
- Secondary amenorrhea: ⥠3 mo (regular) / 6 mo (irregular)
- Dysmenorrhea primary: PG; NSAID 1st line
- Endometriosis 3D: dysmenorrhea + dyspareunia + difficulty pregnancy
- Endometriosis gold dx: laparoscopy + biopsy
- Endometriosis treatment ladder: NSAID â COC â progestin â GnRH agonist/antagonist â surgery
- Fibroid PALM âLâ: heavy menses + bulk + infertility
- GnRH agonist 6 mo limit + add-back HRT (bone)
- Levonorgestrel IUD multi-purpose: AUB, fibroid, adenomyosis, endometriosis
406.2.0.2 â é« yield
406.2.0.2.1 PALM-COEIN
| Letter | Cause |
|---|---|
| P | Polyp |
| A | Adenomyosis |
| L | Leiomyoma (fibroid) |
| M | Malignancy + hyperplasia |
| C | Coagulopathy |
| O | Ovulatory dysfunction |
| E | Endometrial |
| I | Iatrogenic |
| N | Not classified |
406.2.0.2.2 Endometriosis Stage (rASRM)
- I: minimal
- II: mild
- III: moderate
- IV: severe (frozen pelvis)
406.2.0.2.3 Fibroid Treatment Quick
| Goal | Option |
|---|---|
| AUB | NSAID, tranexamic acid, COC, levonorgestrel IUD |
| Pre-op shrinkage | GnRH agonist (3-6 mo) |
| Bulk + AUB | Myomectomy / hysterectomy / UAE / MRgFUS |
| Definitive | Hysterectomy |
| Newer | Elagolix + relugolix (GnRH antagonist) â 22E |
| Off-label | Ulipristal acetate (SPRM) |
406.2.0.2.4 Amenorrhea Workup Algorithm
1. Pregnancy test (always)
2. TSH + prolactin
3. FSH/LH + estradiol
- High FSH â POI
- Low FSH/LH â central (Kallmann, FHA, prolactinoma)
- Normal/low FSH â PCOS
4. Pelvic US
5. Karyotype if primary
6. MRI sella if PRL â or central
7. Progestin challenge â bleed = estrogen present
406.2.0.2.5 Drug Effects on Cycle
| Drug | Effect |
|---|---|
| COC | Suppress (intentional) |
| GnRH agonist | Initial flare â suppress |
| Antipsychotic | â PRL â amenorrhea |
| Tamoxifen | Variable + endometrial CA risk |
| Aromatase inhibitor | Variable |
| Anabolic steroid | Suppress |
| Antithyroid | Restore |
| Spironolactone | Anti-androgen + irregular |
406.2.0.3 ð¯ èªææª¢æž¬
- PALM-COEIN? â P-Polyp / A-Adenomyosis / L-Leiomyoma / M-Malig + hyperplasia / C-Coag / O-Ovulatory / E-Endometrial / I-Iatrogenic / N-Not class
- Heavy bleed? â > 80 mL
- Primary amenorrhea? â No menarche 15 (with sec sex) / 13 (without)
- Endometriosis 3D? â Dysmenorrhea + dyspareunia + difficulty pregnancy
- Endometriosis gold? â Laparoscopy + biopsy
- Endometriosis treatment ladder? â NSAID â COC â progestin â GnRH agonist/antagonist â surgery
- GnRH agonist add-back? â After 6 mo
- Fibroid medical pre-op? â GnRH agonist 3-6 mo
- Levonorgestrel IUD use 4? â AUB, fibroid, adenomyosis, endometriosis
- UAE? â Uterine artery embolization (fibroid)
- Adenomyosis dx? â MRI / TVS / hysterectomy
- Acute pelvic pain ddx? â Ovarian torsion, ectopic, ruptured cyst, PID, appendicitis
- Tranexamic acid? â Heavy menses
- Adolescent heavy menses äžæ¥? â vWD (common)
- Asherman? â Intrauterine adhesion post D&C
â ïž AI èçš¿ã